Jin Sun

66PUBLICATIONS
46CO-AUTHORS
NanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesPredictive and prognostic markersMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jul 21, 2026
Covalent "Locking" of Prodrug Nanoassemblies via Thiol-Ene Click Crosslinking for Potent Antitumor Therapy.

|May 01, 2026
Non-Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual-Pathway T Cell Activation.

|Apr 22, 2026
Modification-Response Integrated Modules Driven Cyclization-Dependent Prodrug Self-Assembly for Reshaping Pro-Apoptotic Tumor Redox Homeostasis.

|Feb 18, 2026
Reprogramming the In Vivo Fate of Nanoassemblies: Morphology Regulation to Rod-Like Nanostructures to Enhance Antitumor Efficacy.

Jingyi Zhang, Tian Liu, Yaqiao Li

|Jan 07, 2026
In Situ Sustained Delivery of Tumor Cell-Derived Extracellular Nanovesicles With Oncolytic Adenoviruses for Potentiating Cancer Immunotherapy.

Tianye Wang, Sheng Zhao, Zao Ji

|Jan 03, 2026
Hydrophobic/Amphiphilic Prodrug Coassembly Strategy: Exploring the Effect of Oligoethylene Glycol Chains on the Antitumor Efficacy of Nanoassemblies.

Jun Yuan, Shuo Wang, Wenjing Wang

Pageof 11

Frequent Collaborators

31 joint publications

Zhonggui He

12 joint publications

Bingjun Sun

9 joint publications

Kaiyuan Wang

3 joint publications

Xiaoyuan Chen